ASTRAZENECA PLC
ASTRAZENECA PLC
Action · GB0009895292 · 886455 (XLON)
Aperçu Indicateurs financiers
106,68 GBP
-98,65 % -7.803,01 GBP
Cours de clôture XLON 06.06.2025: 10.770,00 GBX
London · Cours et graphiques actuels sur MoneyPeak
06.06.2025 17:35

Cours actuels de ASTRAZENECA PLC

BourseTickerDeviseDernier échangeCoursVariation journalière
XETR: XETRA
XETRA
ZEG.DE
EUR
06.06.2025 15:35
127,95 EUR
127,15 EUR
+0,63 %
XLON: London
London
AZN.L
GBX
06.06.2025 15:14
10.770,00 GBX
10.688,00 GBX
+0,77 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
0,00 % 1,11 % -0,82 % -11,62 % -0,54 % -15,34 % 26,15 %

Profil de l'entreprise pour ASTRAZENECA PLC Action

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company's marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Fonds investis

Les fonds suivants ont investi dans : ASTRAZENECA PLC investi :

Fonds
iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc)
Vol. en millions
4.801,23
Part (%)
11,00 %
Fonds
iShares MSCI UK UCITS ETF GBP (Acc)
Vol. en millions
8.928,03
Part (%)
7,25 %
Fonds
iShares Core FTSE 100 UCITS ETF USD Hedged (Acc)
Vol. en millions
8.456,99
Part (%)
6,75 %
Fonds
iShares Core FTSE 100 UCITS ETF GBP (Acc)
Vol. en millions
116.248,56
Part (%)
6,75 %
Fonds
iShares MSCI UK IMI ESG Leaders UCITS ETF GBP (Dist)
Vol. en millions
235,17
Part (%)
4,34 %

Données de l'entreprise

Nom ASTRAZENECA PLC
Société AstraZeneca PLC
Site web https://www.astrazeneca.com
Marché d'origine XLON London
WKN 886455
ISIN GB0009895292
Type de titre Action
Secteur Healthcare
Industrie Drug Manufacturers - General
PDG Mr. Pascal Claude Roland Soriot D.V.M., M.B.A.
Capitalisation boursière 184 Mrd.
Pays Royaume-Uni
Devise GBP
Employés 94,3 T
Adresse 1 Francis Crick Avenue, CB2 0AA Cambridge
Date d'introduction en bourse 2003-12-02
Dividendes de 'ASTRAZENECA PLC'
Date ex-dividende Dividende par action
20.02.2025 133,07 GBX
08.08.2024 60,92 GBX
22.02.2024 123,25 GBX
10.08.2023 56,54 GBX
23.02.2023 135,30 GBX
11.08.2022 76,40 GBX
24.02.2022 108,01 GBX
12.08.2021 46,82 GBX
25.02.2021 98,00 GBX
13.08.2020 53,26 GBX

Symboles boursiers

Nom Symbole
Frankfurt ZEG.F
London AZN.L
XETRA ZEG.DE

Autres actions

Les investisseurs qui détiennent ASTRAZENECA PLC ont également les actions suivantes dans leur portefeuille :
ACCENT GROUP LTD
ACCENT GROUP LTD Action
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Action
AMAZON.CO INC
AMAZON.CO INC Action
AMGEN INC
AMGEN INC Action
APPLE INC
APPLE INC Action
BROADCO INC
BROADCO INC Action
HSBC GIF-HK EQU. P D
HSBC GIF-HK EQU. P D Fonds
META PLATFORMS INC
META PLATFORMS INC Action
MICROSOFT CORP
MICROSOFT CORP Action
MOVEBYBIKE EUROPE AB
MOVEBYBIKE EUROPE AB Action
NVIDIA CORP
NVIDIA CORP Action
ONTRAK INC
ONTRAK INC Action
TESLA INC
TESLA INC Action
VISA INC - CLASS A
VISA INC - CLASS A Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025